ArticleHepatology (Baltimore, Md.)2019

Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma.

Hung Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.